← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 1, 2012Last known activity
Dec 1, 2015
Acquired by Phio Pharmaceuticals on Nov 19, 2018
Timeline
2010s
- Mar 31, 2011
Apthera— Acquired
- Jun 1, 2011
RXi Pharmaceuticals— Founded
- Oct 12, 2016
MirImmune— Acquired
- Nov 19, 2018
Phio Pharmaceuticals— Acquired By
Drugs by trial phase (2 distinct, 7 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Subsidiaries (2 direct, 2 total across the full acquisition tree)
Recent trials (12)
- NCT02640820Lead sponsorPhase 2Dec 1, 2015
- NCT02640820Study directorPhase 2Dec 1, 2015
- NCT02599064Study directorPhase 1/Phase 2Nov 1, 2015
- NCT02599064Lead sponsorPhase 1/Phase 2Nov 1, 2015
- NCT02246465Lead sponsorPhase 2Jul 1, 2014
- NCT02246465Study directorPhase 2Jul 1, 2014
- NCT02079168Study directorPhase 2Mar 1, 2014
- NCT02079168Lead sponsorPhase 2Mar 1, 2014
- NCT02030275Lead sponsorPhase 2Nov 1, 2013
- NCT02030275Study directorPhase 2Nov 1, 2013
- NCT01780077Lead sponsorPhase 1Dec 1, 2012
- NCT01640912Lead sponsorPhase 1Jun 1, 2012
Details
- Founded
- Worcester, MA, US Jun 1, 2011
- Last known activity
- Dec 1, 2015